Agonist efficacy at the B2AR is driven by agonist-induced differences in receptor affinity for the Gs protein, not ligand binding kinetics.
C. R. Harwood, D. A. Sykes, T. Redfern-Nichols, G. Ladds, S. J. Briddon, D. Veprintsev
This study shows that agonist efficacy at the {beta}2AR is determined by differences in receptor affinity for Gs protein, not ligand binding kinetics.
bioRxiv · Jan 5, 2024 · PreprintPharmacology & Toxicology